Search Results
Results found for "Heidi E. Hamm"
- Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
cytokines, and, recently, gene editing techniques, have been tested to reduce the malignancy and generate a harmful
- G protein-coupled receptors that influence lifespan of human and animal models
We also discuss the possibility of using agonist or antagonist drugs, depending on the beneficial or harmful
- Ode to GPCRs
E. Nobel Prize: Three Named for Medicine, Physiology Award. Ekaterini Tiligada, C., Tiligada, E. & Ennis, M.
- Purpose-Driven Opioid Research: Catherine Demery’s Academic Path
Rather than treating opioid pharmacology as a purely theoretical exercise, she collaborates with harm-reduction
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
specifically opioid receptors — using biased agonists that could activate beneficial pathways while avoiding harmful
- Why Opposing Processes Matter for Your Next GPCR Drug
You’ll understand why this is good news, not bad data, and how it can actually prevent harmful reflex
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
By collaborating with harm-reduction groups such as the Red Project in Grand Rapids , she ensures her
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
The cytotoxic drug Monomethyl auristatin E (MMAE) was used alone or conjugated to either the native CCL5
